Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

SAGE Sage Therapeutics Inc

12,10

0,39 (3,33%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sage Therapeutics Charts.

Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sage Therapeutics Charts.

News Sage Therapeutics Inc

Sage Therapeutics to Participate in Upcoming May Investor Conferences
Dienstag 7 Mai 2024 (1 Woche vor) • Business Wire

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Donnerstag 25 April 2024 (3 Wochen vor) • Business Wire

Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Mittwoch 17 April 2024 (4 Wochen vor) • Business Wire

Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
Donnerstag 11 April 2024 (1 Monat vor) • Business Wire

Sage Therapeutics to Present at Upcoming March Investor Conferences
Mittwoch 28 Februar 2024 (3 Monate vor) • Business Wire

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
Mittwoch 21 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Sage Therapeutics Inc News-Artikel

Progressive Planet Solut... (QB)

Mydecine Innovations

Kitanotatsujin (PK)

Harvia OYJ (PK)

Tenzing Acquisition

Vanguard VUCP iNAV

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen